We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Medical Solutn | MLS | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 7.72 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 7.72 | 7.72 |
| Top Posts |
|---|
Posted at 20/2/2008 09:44 by gogoalex I hear all about history etc but as a new investor this company and management team appear to be delivering and when this becomes apparent this stock will fly. I tried to buy 250,000 yesterday and my broker could not get them them, buywell dont be misled by advfn on sales of shares, this share is traded on plus as well and the trades dont show on advfn, I discovered that when my purchases did not appear on advfn. |
Posted at 20/2/2008 08:39 by scribble99999 The mood is far more positive for this company but lets not forget that it will take more than a few announcements to move this shareprice anywhere, given the history of losses. Investors need to see that this company has turned a corner and is capable of making profits and paying dividends before we see new investors buying in and moving the share price.Remember that 130k shares is only £10k worth and that shows that we are in the very early stages of the turnaround (hopefully) and we have a way to go yet. |
Posted at 19/2/2008 18:29 by buywell2 POST REMOVED |
Posted at 14/2/2008 11:08 by suicidesid2 rp,I agree, they are just trying to draw a line under the failures of the past management. Having said that, I am more hopeful that the company is turning things around and attracting new investors such as Jim Mellion who is no mug, and Mr Turnbull actually bought some shares. Perhaps (warranty) and others including myself, may get our original investment back as we've been here since the old turnpyke days which was a few name changes ago. SS2 |
Posted at 11/2/2008 23:06 by paulo dicanio Well over the years many other stocks similar make these super announcements which to most of us small investors "sound super" but there is never any indication of revenues !chastity , regarding your recent post . If you would care to read back on this thread you will see, I have mentioned a few times " That it will be interesting to see how the cash in bank is holding up " In next results ! As far as your losses question ... I'm hoping MLS are in Profit this time round ! Like everyone else ? Let's wait and see as always ! But in the meantime come on MLS give us a Results Date Please ! |
Posted at 02/9/2007 15:33 by lbo FTJune 16th The entire board at Medical Solutions added shares last Friday just a fortnight before the trading guillotine falls ahead of interim results due in August. The shares have bubbled up a third since reaching a six- month low in March. FT 2nd Spetember Weekend Share Watch: Medical Solutions: investors should wait for the interims on September 10 |
Posted at 02/9/2007 15:20 by lbo Medical Solutions cuts costsCompanies: MLS 22/08/2007 Imminent interims from Medical Solutions should confirm the bombed-out diagnostic group's progress in the direction of profitability. Fully listed Medical which found it hard to make money with its original imaging technology for remote pathology reporting and lost £2.3 million last year is sitting on £14 million cash following the £16 million sale of its pathology services joint venture in Dubai. Managing director Nick Ash, former finance chief at Humberside-based Eastern Airlines, joined Medical to pull off that sale and is now focused on exploiting new openings (in cervical cancer screening and other areas) helped by the recent £3.9 million acquisition of Cambridge-headquarte The company has also become the exclusive UK distributor of US group Genomic Health's Oncotype DXC breast cancer assay. Medical Solutions has a five-year contract with the National Health Service for its cytology cancer screening service, which it expects to contribute £4 million to turnover this year. Ash describes cytology as the 'cash cow' of the company. He says the next step is cost-efficient 'semi-automatic guided screening', which Medical is pioneering at Nottingham City Hospital. Medical can now provide gene mutation tests for cancer, argues Ash. He contends that it is able to offer pharmaceutical companies a 'one-stop shop' for new product testing in this field at the pre-clinical trial and phase 1 testing stages. Broker Nomura sees the company eliminating annual losses by 2010. The shares, which traded at 96p six years ago, now languish at 6.75p, valuing the company at £13.75 million, and offer a recovery gamble for the risk-friendly investor. |
Posted at 14/8/2007 09:40 by par12 The funny thing about small investors is they hold when they should sell; and then sell when they should buy; Its crazy but very true |
Posted at 10/8/2007 10:02 by par12 Yep its just to wait; Well oversold so no reason to buy through the silly season; Investors get to much sun and will sell for low prices; Thats not happened yet ! |
Posted at 04/7/2007 16:16 by scribble99999 I don't find it hard to believe they have not been bought out. Why would anyone want to buy a loss making company? Over the last 5 years this company has burned up £27m of investors cash, including mine. Until it starts to make profits no one in going to be interested and given that its losses extend over so many years it will take solid results to get anyone to notice. We are at the beginning of the turnaround but what we need is profits by year end. Reduced losses are no use to anyone. Anyone can run a company that makes no money, it's not difficult.I personally would like to see them stop spending any more money on acquiring other companies until they have got their house in order. I am worried that having just exchanged £15m of intangable assets for £15m in cash (a great move forward) that it is burning a hole in the boards pocket and they are going on a spending spree. The £9m or so that is left can earn minimum 6% per annum just in interest, so unless a company they want to buy is making profits of £540k pa, then the cash should stay in the bank. The big problem sometimes of having large cash resources behind you is that it stiffles the need for efficiency. I think that before buying anything else the Company needs to make the existing business profitable, otherwise buying up other companies and using their profits to offset losses in the core business can just masks fundamental flaws in the business plan. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
